Accelerated atherosclerosis in patients with Wegener's granulomatosis

被引:123
作者
de Leeuw, K
Sanders, JS
Stegeman, C
Smit, A
Kallenberg, CG
Bijl, M
机构
[1] Univ Hosp, Dept Internal Med, Div Clin Immunol, NL-9700 RB Groningen, Netherlands
[2] Univ Hosp, Dept Nephrol, NL-9700 RB Groningen, Netherlands
[3] Univ Hosp, Dept Vasc Dis, NL-9700 RB Groningen, Netherlands
关键词
D O I
10.1136/ard.2004.029033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Several autoimmune disorders are complicated by excess cardiovascular disease. In addition to traditional risk factors, non-traditional risk factors such as endothelial activation and excessive vascular remodelling might be determinants of the progression of atherosclerosis in patients with an autoimmune disease. Objective: To evaluate whether patients with Wegener's granulomatosis (WG) have an increased prevalence of atherosclerosis and to determine predisposing factors. Methods: 29 WG patients ( 19 men; mean (SD) age, 53 ( 14) years) with inactive disease and 26 controls ( 16 men; age 53 ( 15) years) were studied. Common carotid intima - media thickness (IMT) was measured by ultrasound. In all individuals traditional risk factors for cardiovascular disease were determined. High sensitivity C reactive protein (hsCRP) was measured. Endothelial activation was assessed by measuring thrombomodulin, vascular cell adhesion molecule-1, and von Willebrand factor. As a marker of vascular remodelling matrix metalloproteinases (MMP-3 and MMP-9) and TIMP-1 were measured. Results: IMT was increased in WG patients compared with controls ( p< 0.05). No differences in traditional risk factors and endothelial activation markers between patients and controls were found. Levels of hsCRP, MMPs, and TIMP-1 were increased in WG patients ( p< 0.05). Conclusions: Increased IMT found in WG patients cannot be explained by an increased prevalence of traditional risk factors. Although endothelial activation markers in WG patients with inactive disease were not increased, the raised levels of hsCRP, MMPs, and TIMP-1 suggest that enhanced inflammation and excessive vascular remodelling are contributing factors in the development of accelerated atherosclerosis in WG.
引用
收藏
页码:753 / 759
页数:7
相关论文
共 50 条
  • [41] Expression of matrix metalloproteinases in patients with Wegener's granulomatosis
    Bjerkeli, V
    Halvorsen, B
    Damås, JK
    Nordoy, I
    Yndestad, A
    Aukrust, P
    Froland, SS
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (12) : 1659 - 1663
  • [42] Serum level of sFas in patients with Wegener’s granulomatosis
    Eugene J. Kucharz
    Anna T. Kotulska
    Przemyslaw J. Kotyla
    Magdalena M. Kopeć
    Bogdan Krupnik
    Robert Pieczyrak
    Clinical Rheumatology, 2006, 25 : 117 - 118
  • [43] Serum level of SFAS in patients with Wegener's granulomatosis
    Kucharz, EJ
    Kotulska, AT
    Kopec, MM
    Kotyla, PJ
    Krupnik, B
    Pieczyrak, R
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 315 - 315
  • [44] Localized Wegener's granulomatosis
    Marzano, A. V.
    Balice, Y.
    Papini, M.
    Testa, R.
    Berti, E.
    Crosti, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (12) : 1466 - 1470
  • [45] Wegener's Granulomatosis of the Orbit
    Yazici, Bulent
    Demir, Nedime Deveci
    Bilek, Gokben
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2010, 40 (01): : 53 - 56
  • [46] Wegener's granulomatosis in children
    Taris, C
    Choulot, JJ
    Cales, V
    Laborde, Y
    Saint-Martin, J
    Doireau, V
    Mensire, A
    ANNALES DE PEDIATRIE, 1999, 46 (09): : 609 - 612
  • [47] Clinical manifestations in Mexican patients with Wegener's granulomatosis
    De los Rios, D
    Flores-Suarez, L
    Arellanes, L
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U991 - U991
  • [48] Sinonasal computed tomography in patients with Wegener's granulomatosis
    Lohrmann, C
    Uhl, M
    Warnatz, K
    Kotter, E
    Ghanem, N
    Langer, M
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2006, 30 (01) : 122 - 125
  • [49] Serum level of sFas in patients with Wegener's granulomatosis
    Kucharz, EJ
    Kotulska, AT
    Kotyla, PJ
    Kopec, MM
    Krupnik, B
    Pieczyrak, R
    CLINICAL RHEUMATOLOGY, 2006, 25 (01) : 117 - 118
  • [50] Therapeutics of Wegener's granulomatosis
    Peter K Wung
    John H Stone
    Nature Clinical Practice Rheumatology, 2006, 2 : 192 - 200